ReviewCurrent oncology reports2026
Gender, Sex and Other Factors in the Development of Neuroendocrine Neoplasms.
Review in Current oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo examine how biological sex and gender influence the tumorigenesis of neuroendocrine neoplasms (NEN), integrating epidemiological evidence with hormonal, molecular, lifestyle and environmental factors. RECENT
findingsRecent population-based studies demonstrate sex differences in NEN incidence, pathological characteristics and survival across multiple anatomical sites. Emerging evidence suggests that sex-hormone signalling, epigenetic regulation and the tumour microenvironment may contribute to these differences. Lifestyle and metabolic factors, including smoking and obesity, may further modify NEN susceptibility and interact with sex- and gender-related factors. Biological sex appears to be an important modifier of NEN development rather than simply a demographic characteristic. However, mechanistic evidence remains limited and the contribution of gender is poorly characterised. Prospective, sex-stratified studies integrating hormonal, molecular and environmental data are required to clarify these interactions and their potential clinical relevance.
Indexed as
Identifiers
42742899What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.